期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

^(18)F-FDG PET及PET/CT在胰腺癌临床应用中的价值 被引量：3

The clinical value of ^(18)F-FDG PET and PET/CT applied to pancreatic cancer
下载PDF
导出
摘要 胰腺癌是最常见的消化系统恶性肿瘤之一,早期诊断难度大,预后极差。18F-脱氧葡萄糖(FDG)PET/CT将PET的功能显像与CT的解剖成像有机融合,不仅能有效显示肿瘤的代谢、增生、乏氧和细胞凋亡状态,而且能精确显示肿瘤组织与周围脏器组织的解剖结构关系,探查全身淋巴结及远处转移情况,在胰腺癌患者的诊断、分期、指导治疗、疗效监控和预后评价等方面,PET/CT都具有重要的临床应用价值。本文将就18F-FDG PET及PET/CT在胰腺癌临床应用中的价值进行综述。 Pancreatic cancer is one of malignant tumors in the digestive system,which has difficult diagnosis in early stage,and poor prognosis.Positron emission tomography/computed tomography（PET/CT）,combines the functional imaging of PET and the anatomic imaging of CT can efficiently image tumor metabolism,proliferation,hypoxia and cell apoptosis.It can also precisely image the anatomic structure of tumors and their adjacent organs or tissues,locate lymph nodes and metastases of body as a whole,PET/CT was found to be particularly helpful for guiding diagnosis,staging,monitoring therapy and in evaluating the prognosis of patients with pancreatic cancer.
作者 刘长存 赵晋华
机构地区 上海交通大学附属第一人民医院核医学科
出处 《现代肿瘤医学》 CAS 2010年第11期2273-2276,共4页 Journal of Modern Oncology
关键词 胰腺肿瘤 体层摄影术 发射型计算机 临床应用 pancreatic neoplasms tomography emission-computed clinical application
分类号 R735.9 [医药卫生—肿瘤]
  • 相关文献

参考文献25

  • 1Wray CJ,Ahmad SA,Matthews,et al.Surgery for pancreatic cancer:recent controversies and current practice[J].Gastroenterology,2005,128(6):1626-1641.
  • 2Papos M,Takacs T,Pavics L,et al.The role of FDG-PET scan in the diagnosis of pancreatic carcinoma[J].Orv Hetil,2002,143(21 suppl 3):1283-1286.
  • 3Valk PE,Bailey DL,Townsend DW,et al.Positron emission tomography:basic science and clinical practice[J].Springer Press,2003,2:588 -594.
  • 4Reske SN,Grillenberer KG,Glatting G,et al.Overexpression of glucose transporter 1 and increased FDG uptake in pancreatic carcinoma[J].J Nucl Med,1997,38(9):1344-1348.
  • 5Friess H,Langhans J,Ebert M,et al.Diagnosis of pancreatic cancer by 2[18F] -fluoro-2-deoxy-D-glucose positron emission tomography[J].Gut,1995,36(5):771-777.
  • 6Rose DM,Delbeke D,Beauchamp RD,et al.18F luorodeoxyglucose-positron emission tomography in the management of patients with suspected pancreatic cancer[J].Ann Surg,1998,229(5):729-738.
  • 7Diederichs CG,Staib L,Vogel J,et al.Values and limitations of 18F-fluoroglucose-positron-emission tomography with preoperative evaluation of patients with pancreatic masses[J].Pancreas,2000,20(2):109-116.
  • 8Zimny M,Barcs R,Fass J,et al.Fluorine-18 fluorodeoxyglucose positron emission tomography in the differential diagnosis of pancreatic carcinoma:a report of 106 cases[J].Eur J Nucl Med,1997,24(6):678-682.
  • 9Keoqan MT,Tyler D,Clark L,et al.Diagnosis of pancreatic carcinoma:role of FDG PET[J].Am J Roentgenol,1998,171(6):1565-1570.
  • 10Michl P,Pauls S,Gress TM.Evidence-based diagnosis and staging of pancreatic cancer[J].Best Pract Res Clin Gastroenterol,2006,20(2):227-251.

二级参考文献46

  • 1王荣福.肿瘤影像核医学进展[J].中国医学影像技术,2004,20(11):1792-1796. 被引量：16
  • 2王中秋,卢光明,郑玲,朱虹,常林风,吴江,秦莉萍.PET/CT及其他影像手段对胰腺癌诊断的比较研究[J].医学影像学杂志,2006,16(1):84-87. 被引量：17
  • 3Hamer OW, Feuerbach S. How useful is integrated PET and CT for the management of pancreatic cancer? Nat Clin Pract Gastroenterol Hepatol, 2006, 3: 74-75.
  • 4Orlando LA, Kulasingam SL, Matchar DB. Meta-analysis: the detection of pancreatic malignancy with positron emission tornography. Aliment Pharmacol Ther, 2004, 20: 1063-1070.
  • 5Stollfuss JC, Glatting G, Friess H, et al. 2-18F-fluoro-2-deoxy-Dglucose PET in detection of pancreatic cancer: value of quantitative image interpretation. Radiology, 1995, 195 : 339-344.
  • 6Delbeke D, Rose DM, Chapman WC, et al. Optimal interpretation of FDG PET in the diagnosis, staging and management of pancreatic carcinoma. J Nucl Med, 1999, 40: 1784-1791.
  • 7Sundin A, Eriksson B, Bergstrom M, et al. PET in the diagnosis of neuroendocrine tumors. Ann NY Acad Sci, 2004, 1014: 246-257.
  • 8Zhao S, Kuge Y, Mochizuki T, et al. Biologic correlates of intratumoral heterogeneity in 18SF-FDG distribution with regional expression of glucose transporters and hexnkinase-II in experimental tumor. J Nucl Med, 2005, 46: 675-582.
  • 9Lemke A J, Niehues SM, Hosten N, et al. Retrospective digital image fusion of muhidetector CT and 18F-FDG PET: clinical value in pancreatic lesions a prospective study with 104 patients. J Nucl Med, 2004, 45 : 1279-1286.
  • 10Heinrich S, Goerres GW, Schafer M, et al. Positron emission tomography/computed tomography influences on the management of resectable pancreatic cancer and its cosl-effetiveness. Ann Surg, 2005, 242: 235-243.

共引文献38

同被引文献31

  • 1胡荣剑,姚稚明,潘纪戍,李伟,韩丽君,周诚,屈婉莹.^(18)F-FDG PET/CT和增强CT对胰腺病变定性诊断的价值比较[J].中华核医学杂志,2007,27(2):68-72. 被引量：8
  • 2Nishiyama Y, Yamamoto Y, Monden T, et al. Evaluation of delayed additional FDG PET imaging in patients with pancreatic tumor. Nucl Med Commun, 2005, 26: 895-901.
  • 3Kate K, Nihashi T, Ikeda M, et,al. Limited efficacy of (18) F-FDG PET/CT for differentiation between metastasis- free pancreatic cancer and mass-forming pancreatitis. Clin Nucl Med, 2013,38:417-421.
  • 4Schellenberg D, Quon A, Minn AY, et al. 18FluorodeoxyglucosePET is prognostic of progression-free and overall survival in locallyadvanced pancreas cancer treated with stereotactic radiotherapy. Int J Radiat Oncol BiolPhys, 2010, 77: 1420-1425.
  • 5Hu SL, Yang ZY, Zhou ZR, et al. Role of SUV(max) obtained by 18F-FDG PET/CT in patients with a solitary pancreatic lesion: predicting malignant potential and proliferation. Nucl Med Commun, 2013, 34: 533-539.
  • 6Moon SY, Joo KR, So YR, et, al. Predictive Value of Maximum Standardized Uptake Value (SUVmax) on 18F-FDG PET/CT in Patients With Locally Advanced or Metastatic Pancreatic Cancer. Clin Nucl Med, 2013, 38: 778-783.
  • 7Kauhanen SP, Komar G, Sepplinen MP, et al. A prospective diagnostic accuracy study of~SF-fluoredeoxyglueose positron emission tomography/computed tomography, multidetectorrow computed tomography, and magnetic resonance imaging in primary diagnosis and staging of panceatic cancer[J]. Ann Surg, 2009, 250: 957-963.
  • 8Kysucan J, Lovecek M, Klos D, et al. Benefit of PET/CT in thepreoperative staging in pancreatic carcinomas. RozhlChir, 2010, 89: 433-440.
  • 9Kim M J, Lee KH, Lee KT, et al. The Value of Positron Emission Tomography/Computed Tomography for Evaluating Metastatic Disease in Patients With Pancreatic Cancer.Pancreas, 2012,41:897- 903.
  • 10Choi M, Heilbrun LK, Venkatramanamoorthy R, et al. Using 18F-fluorodeoxyglucose positron emission tomographyto monitor clinical outcomes in patients treated withneoadjuvantchemo- radiotherapy for locally advanced pancreaticcancer . Am J ClinOncol, 2010, 33: 257-261.

引证文献3

二级引证文献7

现代肿瘤医学
2010年 第11期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部